Home Shop TRAIL (human) monoclonal antibody (III6F)

TRAIL (human) monoclonal antibody (III6F)

Already have an account?

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

This antibody is covered by our Worry-Free Guarantee.

Alternative Name	Apo-2L, TNFSF 10, CD253
Application	ELISA, Flow Cytometry, IHC (FS), IP, WB
Clone	III6F
Formulation	Liquid. In PBS containing 0.02% sodium azide.
GenBank ID	U57059
Gene/Protein Identifier	8743 (Entrez GeneID)
Host	Mouse
Immunogen	Recombinant human soluble TRAIL.
Isotype	IgG2b
Source	Purified from hybridoma tissue culture supernatant.
Species Reactivity	Human
UniProt ID	P50591
Worry-free Guarantee	This antibody is covered by our Worry-Free Guarantee.

Use/Stability	Stable for at least 1 year after receipt when stored as recommended.
Handling	Avoid freeze/thaw cycles.
Short Term Storage	+4°C
Long Term Storage	-20°C
Shipping	Blue Ice

Regulatory Status	RUO – Research Use Only

Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma: K.A. Salva, et al.; Photochem. Photobiol. 94, 1058 (2018), Application(s): Multispectral imaging of immunostained cytopreparations, Abstract
Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer: B. Yoldas, et al.; Head Neck 33, 1278 (2011), Abstract
Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer: Koksal, I. T., Sanlioglu, A. D., et al.; Urol. Int. 84, 445 (2010), Abstract
High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas: A.D. Sanlioglu, et al.; Pancreas 36, 385 (2008), Abstract — Full Text
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA: N.B. Liabakk, et al.; J. Immunol. Method. 259, 119 (2002), Abstract